Humoral response and safety of the BNT162b2 and mRNA‐1273 COVID‐19 vaccines in patients with haematological diseases treated with anti‐CD20 antibodies: An observational study. (20th March 2022)

• Record Type: Journal Article
• Authors: Nishikubo, Masashi; Shimomura, Yoshimitsu; Maruoka, Hayato; Nasu, Seiko; Nishioka, Tomomi; Sakizono, Kenji; Mitsuyuki, Satoshi; Kubo, Tomoyo; Okada, Naoki; Nakagawa, Daishi; Kamijo, Kimimori; Imoto, Hiroharu; Yamamoto, Ryusuke; Nagai, Yuya; Hiramoto, Nobuhiro; Yoshioka, Satoshi; Yonetani, Noboru; Matsushita, Akiko; Miyakoshi, Chisato; Doi, Asako; Ishikawa, Takayuki
• Is Part Of: British journal of haematology. Volume 197:Number 6(2022)
• Page Start: 709
• Page End: 713
• Publication Date: 2022-03-20
• Subjects: BNT162b2 -- COVID‐19 -- haematological disorders -- mRNA‐1273 -- obinutuzumab -- rituximab; Hematology -- Periodicals; Blood -- Diseases -- Periodicals; 616.15
• DOI: 10.1111/bjh.18151
• Languages: English
• ISSNs: 0007-1048